Lipocine Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
45,263.70
27,666.10
44,382.80
26,840.30
21,468.10
20,250.60
Total Accounts Receivable
-
-
144.50
38.90
3,343.00
38.50
Other Current Assets
770.00
229.90
350.20
329.50
408.20
520.10
Total Current Assets
46,033.70
27,896.00
44,877.50
27,208.80
25,219.30
20,809.20
Net Property, Plant & Equipment
28.80
73.80
75.80
103.40
75.10
19
Total Investments and Advances
-
-
400.30
-
-
-
Other Assets
45.00
23.80
23.80
30.80
30.80
23.80
Total Assets
46,107.50
27,993.50
45,377.30
27,343.00
25,325.10
20,852
Accounts Payable
1,027.00
-
-
-
598.10
Other Current Liabilities
256.80
1,633.50
3,391.90
1,326.20
5,747.10
Total Current Liabilities
1,283.80
1,633.50
3,391.90
1,326.20
6,345.10
Total Liabilities
1,283.80
1,633.50
3,391.90
1,326.20
6,345.10
Common Equity (Total)
44,823.70
26,360.00
41,985.40
26,016.80
18,980.00
Total Shareholders' Equity
44,823.70
26,360.00
41,985.40
26,016.80
18,980.00
Total Equity
44,823.70
26,360.00
41,985.40
26,016.80
18,980.00
Liabilities & Shareholders' Equity
46,107.50
27,993.50
45,377.30
27,343.00
25,325.10
About Lipocine
View Profile
